Drug · DIN 02512629
CEQUA
SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 8, 2022; first marketed November 4, 2021.
- Drug Identification Number (DIN)
- 02512629
- Company (DIN owner)
- Sun Pharmaceutical Industries LimitedMumbai, Maharashtra, India
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Ciclosporin S01XA18
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CYCLOSPORINE | 0.09 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 10, 2022: NOC 27364New Drug Submission (NDS) · Administrative: Merger/Buy-out
- February 16, 2021: NOC 25234New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “cequa”. A notice may cover another product or only some lots: read it to see what it covers.
- CEQUA: Out of SpecificationSeptember 6, 2023 · Drugs · Other · Type II